ID   CMA-03/06
AC   CVCL_2G61
SY   CMA-03_06; CMA03/06
DR   EFO; EFO_0006553
DR   Cosmic; 2391809
DR   GEO; GSM977757
DR   GEO; GSM977758
DR   GEO; GSM977759
DR   Wikidata; Q54813732
RX   PubMed=24327544;
CC   Characteristics: Compared to the parent cell line, not IL6 dependent.
CC   Doubling time: ~80 hours (PubMed=24327544).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M486 ! CMA-03
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
RX   PubMed=24327544; DOI=10.1002/gcc.22127;
RA   Verdelli D., Nobili L., Todoerti K., Mosca L., Fabris S., D'Anca M.,
RA   Pellegrino E., Piva R., Inghirami G., Capelli C., Introna M.,
RA   Baldini L., Chiaramonte R., Lombardi L., Neri A.;
RT   "Molecular events underlying interleukin-6 independence in a subclone
RT   of the CMA-03 multiple myeloma cell line.";
RL   Genes Chromosomes Cancer 53:154-167(2014).
//